Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04ZXP
|
|||
Former ID |
DIB003698
|
|||
Drug Name |
Dicycloplatin
|
|||
Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Registered | [1] | |
Company |
Peking University
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H20N2O8Pt
|
|||
Canonical SMILES |
C1CC(C1)(C(=O)O)C(=O)O.C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2]
|
|||
InChI |
1S/2C6H8O4.2H3N.Pt/c2*7-4(8)6(5(9)10)2-1-3-6;;;/h2*1-3H2,(H,7,8)(H,9,10);2*1H3;/q;;;;+2/p-2
|
|||
InChIKey |
IIJQICKYWPGJDT-UHFFFAOYSA-L
|
|||
CAS Number |
CAS 287402-09-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Human Deoxyribonucleic acid (hDNA) | Target Info | Inhibitor | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031375) | |||
REF 2 | Dicycloplatin, a novel platinum analog in chemotherapy: synthesis of chinese pre-clinical and clinical profile and emerging mechanistic studies. Anticancer Res. 2014 Jan;34(1):455-63. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.